반응식
ClC1C=C(Cl)C=CC=1C([C:13]1[C:21]2[C:16](=[C:17]([CH2:23][S:24][CH3:25])[CH:18]=[C:19](F)[CH:20]=2)[NH:15][CH:14]=1)CCO.[CH:26]1([C:29]([C:32]2[CH:37]=[CH:36][C:35]([F:38])=[CH:34][C:33]=2[F:39])(O)[CH3:30])[CH2:28][CH2:27]1.C1(C(C2C3C(=C(CSC)C=CC=3)NC=2)(C2C=CC(F)=CC=2)C)CC1>>[CH:26]1([C:29]([C:13]2[C:21]3[C:16](=[C:17]([CH2:23][S:24][CH3:25])[CH:18]=[CH:19][CH:20]=3)[NH:15][CH:14]=2)([C:32]2[CH:37]=[CH:36][C:35]([F:38])=[CH:34][C:33]=2[F:39])[CH3:30])[CH2:28][CH2:27]1참가 물질
4
반응물 3
생성물 1
실험 절차
The title compound was prepared starting from 500 mg (2.82 mmol) of the compound from Example 8 and 615 mg (3.10 mmol) of the compound from Example 78A in analogy to the synthesis of the compound from Example 95. 227 mg (94% purity, 21% of theory) of the target compound were obtained.
후처리
- custom227 mg (94% purity, 21% of theory) of the target compound were obtained
출처 및 근거
- ORD 기록
- ord-5872915fca674e66b19df19edad8cc3e
- 출처 데이터셋
- uspto-grants-2011_11
- 특허 번호
- US08063234B2
연결된 노트
불러오는 중…